CD40LG and leprosy: Additionally, in 16/64 villages, anti-M. leprae phenolic glycolipid-I (anti-PGL-I) IgM levels were measured for three consecutive years, in newly diagnosed leprosy patients and more than 17,000 household- and neighbourhood contacts who had been screened for signs of leprosy.